1.86

0.54% 0.01

After Hours: 1.82 -0.04 -2.15%

Clearmind Medicine Inc (CMND)

Overview News Price History Why CMND Down? Discussions Forecast Stock Split

Clearmind Medicine Inc stock is traded at $1.86, with a volume of 35,686. It is up +0.54% in the last 24 hours and down -3.63% over the past month. Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Previous Close:

$1.85

Open:

$1.88

24h Volume:

35,686

Relative Volume:

0.02

Market Cap:

$2.76M

Revenue:

Net Income/Loss:

$-7.90M

P/E Ratio:

-0.01

EPS:

-185.9263

Net Cash Flow:

$-6.29M

1W Performance:

+14.11%

1M Performance:

-3.63%

6M Performance:

-83.39%

1Y Performance:

-99.54%

1-Day Range:

$1.82

$1.8899

1-Week Range:

$1.54

$1.8899

52-Week Range:

$1.43

$524.00

Clearmind Medicine Inc Stock (CMND) Company Profile

Name

Clearmind Medicine Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-09-10

Latest SEC Filings

CMND's Discussions on Twitter

Compare CMND vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CMND Clearmind Medicine Inc	1.86	2.45M	0	-7.90M	-6.29M	-185.93
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Clearmind Medicine Inc Stock (CMND) Latest News

Aug 13, 2026

Why Did CMND Stock Jump 40% Today? - Stocktwits

Aug 13, 2026

Clearmind Medicine Makes Clinical Progress in Alcohol Addiction Treatment Trial - Benzinga

Aug 13, 2026

Clearmind Medicine Receives DSMB Approval to Advance CMND-100 Clinical Trial in Patients With Alcohol Use Disorder - Quiver Quantitative

Aug 13, 2026

Clearmind's CMND-100 Will Be Tested in People With Alcohol Use Disorder - Stock Titan

Aug 13, 2026

Clearmind Medicine Inc. (NASDAQ:CMND) - intelligentinvestor.com.au

Aug 13, 2026

Aug 12, 2026

Clearmind Medicine (CMND) holders report 9.99% cap on warrant-based stake - Stock Titan

Aug 12, 2026

Aug 11, 2026

Clearmind Medicine (CMND) reports intranasal MEAI permeation near 98% in study - Stock Titan

Aug 11, 2026

Clearmind Medicine Announces Positive Permeation Results For Intranasal Meai Formulation - TradingView

Aug 11, 2026

Clearmind Medicine Reports Positive Permeation Results for Intranasal MEAI Program - Quiver Quantitative

Aug 11, 2026

Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, ... - Enidnews.com

Aug 11, 2026

Clearmind’s nasal MEAI stays longer on tissue with comparable drug transport - Stock Titan

Aug 11, 2026

Aug 06, 2026

Clearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock Titan

Aug 06, 2026

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study - The Manila Times

Aug 06, 2026

CMND-100 Set to Enter Human Testing for Moderate-to-Severe Alcohol Use Disorder - Stock Titan

Aug 06, 2026

Clearmind advances CMND-100 alcohol use disorder trial into patient testing after Phase I safety readout - Bitget

Aug 06, 2026

Aug 03, 2026

Clearmind Medicine to acquire 51% stake in EV charging firm By Investing.com - Investing.com Nigeria

Aug 03, 2026

Clearmind Medicine Signs Letter Of Intent To Acquire 51% Majority Stake In Ev Wireless Charging Solutions For Automated Parking Systems Company - TradingView

Aug 03, 2026

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company - The Manila Times

Aug 03, 2026

Clearmind Medicine (Nasdaq: CMND) signs LOI for 51% EV charging stake - Stock Titan

Aug 03, 2026

Clearmind Medicine to acquire 51% stake in EV w... - Pluang

Aug 03, 2026

Jul 30, 2026

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial - The Manila Times

Jul 30, 2026

Jul 28, 2026

Clearmind completes Part A of FDA-regulated tri... - Pluang

Jul 28, 2026

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial - The Manila Times

Jul 28, 2026

Clearmind Medicine Completes Treatment of All Participants in Part A of Phase I/II AUD Trial for CMND-100 - Quiver Quantitative

Jul 28, 2026

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial - GlobeNewswire Inc.

Jul 28, 2026

Jul 27, 2026